Covid-19 Impact On Global Nanotechnology Drug Delivery Market : Industry Analysis and Forecast (2019-2026): By Technology, Application and Region. -…

Posted on by

Global Nanotechnology Drug Delivery Market was valued US$ XX Bn in 2018 and is expected to reach US$ 98.2 Bn by 2026, at a XX% CAGR of around during a forecast period.

Various novel technologies for developing effective drug delivery systems came into existence among which nanotechnology platforms for achieving targeted drug delivery are gaining prominence nowadays. Research in the medical field includes the development of drug nanoparticles, polymeric and inorganic biodegradable nano-carriers for drug delivery, and surface engineering of carrier molecules.

The report contains a detailed list of factors that will drive and restrain the growth of the Nanotechnology Drug Delivery Market. Such as, rapidly expanding areas of research and development to develop novel nano-medicine are expected to drive the nanotechnology drug delivery market growth in the future. Additionally, one of the major factors assisting market growth is the growing prevalence of infectious diseases and cancer, developing nanotechnology research, and increasing demand for novel drug delivery systems. However, high cost coupled with stringent regulatory scenario hinders the market growth to some extent.

Nanoparticles are expected to account for the largest XX% market share by 2026. The segment dominated the market as key nanoparticles like gold nanoparticles, dendrimers, and fullerenes are used in pharmaceutical drug delivery.The report offers a brief analysis of the major regions in the global nanotechnology drug delivery market, namely, APAC, Europe, North America, South America, and the Middle East & Africa. North America dominated the nanotechnology drug delivery market in 2018, because of high medical reimbursement facilities, and technological advancement. The APAC is projected to have the fastest growth, owing to a rapidly increasing population, an increase in consumer awareness, favorable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing economies such as China, and India in this region.

Request For View Sample Report Page :@ https://www.maximizemarketresearch.com/request-sample/39035/

Nanotechnology drug delivery market report gives a competitive analysis of the individual standing of the companies against the global landscape of the medical industry. The forecast also provides the estimated trends in demand for the global market and their impact on the sizes of these companies to help the reader curate profitable business strategies. Such as Pfizer, Inc., AstraZeneca and Amgen signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the upcoming future.

The objective of the report is to present comprehensive analysis of Global Nanotechnology Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Nanotechnology Drug Delivery Market dynamics, structure by analyzing the market segments, and project the Global Nanotechnology Drug Delivery Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nanotechnology Drug Delivery Market make the report investors guide.

Do Inquiry Before Purchasing Report Here: @ https://www.maximizemarketresearch.com/inquiry-before-buying/39035/

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.Scope of the Global Nanotechnology Drug Delivery Market

Global Nanotechnology Drug Delivery Market, by Technology

Nanocrystals Nanoparticleso Dendrimerso Gold Nanoparticleso Dendrimerso Fullereneso Others Liposomes Micelles Nanotubes OthersGlobal Nanotechnology Drug Delivery Market, by Application

Neurology Oncology Cardiovascular/Physiology Anti-inflammatory/Immunology Anti-infective OthersGlobal Nanotechnology Drug Delivery Market, by Region

North America Asia Pacific Europe Middle East & Africa South AmericaKey players operating in the Global Nanotechnology Drug Delivery Market

Johnson & Johnson Merck & Co Roche Bayer Novartis Pharmaceuticals Pfizer AstraZeneca Amgen Celgene Corporation Angiotech Pharmaceuticals Capsulution Pharma AlphaRx Inc. Calando Pharmaceuticals Copernicus Therapeutics Elan Corporation Nanotherapeutics PAR Pharmaceutica Taiwan Liposome Co. AbbVie, Inc

Major Table of Contents Report

Chapter One: Nanotechnology Drug Delivery Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanotechnology Drug Delivery Market Competition, by Players

Chapter Four: Global Nanotechnology Drug Delivery Market Size by Regions

Chapter Five: North America Nanotechnology Drug Delivery Revenue by Countries

Chapter Six: Europe Nanotechnology Drug Delivery Revenue by Countries

Chapter Seven: Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries

Chapter Eight: South America Nanotechnology Drug Delivery Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanotechnology Drug Delivery by Countries

Chapter Ten: Global Nanotechnology Drug Delivery Market Segment by Type

Chapter Eleven: Global Nanotechnology Drug Delivery Market Segment by Application

Chapter Twelve: Global Nanotechnology Drug Delivery Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanotechnology Drug Delivery Market Report at: https://www.maximizemarketresearch.com/market-report/global-nanotechnology-drug-delivery-market/39035/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: Maximize Market Research Pvt. Ltd.

Email: sales@maximizemarketresearch.com

Contact: +919607065656 / +919607195908

Website: http://www.maximizemarketresearch.com

Read the rest here:
Covid-19 Impact On Global Nanotechnology Drug Delivery Market : Industry Analysis and Forecast (2019-2026): By Technology, Application and Region. -...

Evergreen Medical Acupuncture is now offering its own supplement and herbal products, Dr. Ficks Functional Farmacy! – TippNews DAILY

Posted on by

EVERGREEN, Colo., June 9, 2020 (SEND2PRESS NEWSWIRE) Combining the use of Eastern and Western philosophy of Holistic Medicine, Dr. Christina Fick, of Evergreen Medical Acupuncture, has created a carefully selected offering of CGMP (certified good manufacturing practice), and organic certified supplements and herbal products that provide a well-balanced approach to healing.

Evergreen Medical Acupuncture, a locally owned and operated Colorado Business located in Evergreen, Colorado, has always offered the best of Eastern and Western Medicine to its customers, and is happy to announce the new online store for these offering, Dr. Ficks Functional Farmacy, at https://www.drchristinafick.com/functional-farmacy.

With a wide variety of hand-picked, quality herbal supplements with a focus on some of the best practices of Eastern Medicine, Dr. Ficks Functional Farmacy provides clients the ease of online information and recommendations, and the ability to order products from home. Products such as Phyto-Multiplex, a multi-vitamin + phytonutrient + trace mineral supplement, Premium Choline for brain, gut, and general health, and Nutra-Absorb for digestive support, are now ready for the online audience.

Dr. Ficks Functional Farmacy is also offering an exclusive cosmetic line, Skin for Life, and a selection of specialty luxury soaps, called My Soap Box. Skin for Lifes ingredient formulas are in a nutritional nano bio-emulsion sphere that delivers vitamins, minerals, and essential lipids to protect the skins immunity integrity, and the beautifully scented, exotic body and facial bar soaps of My Soap Box are a perfect way to provide an escape from the days stresses, or to provide a truly unique gift for someone dear to you.

We offer the best of Eastern and Western Medicine to our clients The Chinese now see the benefit of modern medicine, and how it can be applied to the practice of Traditional Chinese Medicine, stated Dr. Christina Fick. By combining the best of both worlds, we can achieve sustainable results for our clients using Acupuncture, Specialty Needle Techniques, and our custom-built Acupuncture Clinic. These herbal supplements and new products represent some of our best recommendations, and compliment these techniques, and are now available to clients with a mouse-click.

About Evergreen Medical Acupuncture, Dr. Ficks Functional Farmacy, and Dr. Christina Fick

Located in both Evergreen, Colorado, Evergreen Medical Acupuncture is locally owned and operated. The company and its employees live and work in Colorado, and also offer phone or video chat appointments for consultation to anyone in the nation. The acupuncturists on in the Clinic work closely under Dr. Fick, have been hand-selected and vetted, and go through rigorous ongoing training to provide highest standards of service and customer care.

Dr. Christina Fick is the owner and founder of Evergreen Medical Acupuncture, LLC, first opened in 2012. She holds a Doctorate in Acupuncture and Oriental Medicine, a Masters degree in Herbology, and is certified in Functional Medicine. She has worked globally in her specialized field, in hospitals both in China, and in New York.

For more information about Dr. Ficks Functional Farmacy, and Evergreen Medical Acupuncture, including details about their services and new custom built Acupuncture Clinic, please visit the company website: https://www.drchristinafick.com/, or call to book an appointment or learn more at 303-594-8348.

*PHOTO link for media: https://www.Send2Press.com/300dpi/20-0609s2p-evergreen-med-300dpi.jpg

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

News Source: Evergreen Medical Chiropractic and Acupuncture

To view the original post, visit: https://www.send2press.com/wire/evergreen-medical-acupuncture-is-now-offering-its-own-supplement-and-herbal-products-dr-ficks-functional-farmacy/.

This press release was issued by Send2Press Newswire on behalf of the news source, who is solely responsible for its accuracy. http://www.send2press.com.

See the article here:
Evergreen Medical Acupuncture is now offering its own supplement and herbal products, Dr. Ficks Functional Farmacy! - TippNews DAILY

Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prod | DDDT – Dove Medical Press

Posted on by

Yuan Hong,1 Shaomin Che,2 Beina Hui,2 Xiaoli Wang,2 Xiaozhi Zhang,2 Hailin Ma2

1Department of Medical Imaging, The First Affiliated Hospital of Xian Jiaotong University, Xian, Shaanxi, Peoples Republic of China; 2Department of Oncology Radiotherapy, The First Affiliated Hospital of Xian Jiaotong University, Xian, Shaanxi, Peoples Republic of China

Correspondence: Hailin MaDepartment of Oncology Radiotherapy, The First Affiliated Hospital of Xian Jiaotong University, No. 277 Yanta Xi Road, Xian, Shaanxi 710061, Peoples Republic of ChinaEmail mahlxjtu@sohu.com

Purpose: Lung cancer remains the leading cancer-associated deaths worldwide. Cisplatin (CDDP) was used in combination with curcumin (CUR) for the treatment of non-small cell lung cancer. The aim of this study was to prepare and characterize CDDP prodrug and CUR co-encapsulated layer-by-layer nanoparticles (CDDP-PLGA/CUR LBL NPs) to induce cooperative response, maximize the therapeutic effect, overcome drug resistance, and reduce adverse side effects.Methods: CDDP prodrug (CDDP-PLGA) was synthesized. CDDP-PLGA/CUR LBL NPs were constructed and their physicochemical properties were investigated by particle-size analysis, zeta potential measurement, drug loading, drug entrapment efficiency, and in vitro drug release behavior. In vitro cytotoxicity against human lung adenocarcinoma cell line (A549 cells) was investigated, and in vivo anti-tumor efficiency of CDDP-PLGA/CUR LBL NPs was evaluated on mice bearing A549 cell xenografts.Results: CDDP-PLGA/CUR LBL NPs have a size of 179.6 6.7 nm, a zeta potential value of 29.9 3.2 mV, high drug entrapment efficiency of 85.6 3.9% (CDDP) and 82.1 2.8% (CUR). The drug release of LBL NPs exhibited a sustained behavior, which made it an ideal vehicle for drug delivery. Furthermore, CDDP-PLGA/CUR LBL NPs could significantly enhance in vitro cytotoxicity and in vivo antitumor effect against A549 cells and lung cancer animal model compared to the single drug-loaded LBL NPs and free drug groups.Conclusion: CDDP-PLGA/CUR LBL NPs were reported for the first time in the combination therapy of lung cancer. The results demonstrated that the CDDP-PLGA/CUR LBL NPs might be a novel promising system for the synergetic treatment of lung carcinoma.

Keywords: lung cancer, combination therapy, layer-by-layer, cisplatin prodrug, curcumin

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Follow this link:
Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prod | DDDT - Dove Medical Press

MagForce : Publishes Financial Results for the Year 2019 and Operative Highlights – Marketscreener.com

Posted on by

DGAP-News: MagForce AG / Key word(s): Annual ResultsMagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights (news with additional features)

30.06.2020 / 08:30 The issuer is solely responsible for the content of this announcement.

MagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights

Europe: Successful implementation of the expansion strategy - significant increase in treatment numbers of brain tumor patients (post period)

USA: FDA approval to proceed with its streamlined trial protocol for the next stage of pivotal U.S. single-arm study for the focal ablation of intermediate risk prostate cancer with the NanoTherm therapy system received - first patients enrolled (post period)

Berlin, Germany, and Nevada, USA, June 30, 2020 - MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results as of and for the year ended December 31, 2019 as well as operative highlights.

Operative Highlights

In 2019, MagForce achieved important corporate goals and made decisive progress in its development.

Europe: Faster and easier access to treatment with NanoTherm therapy for brain tumor patients

All Company activities in Europe are aimed at further increasing awareness of the NanoTherm therapy system and making the therapy available to patients: MagForce successfully introduced its 'NanoTherm Therapy School' series, a practice-oriented, unique, multifaceted application training for the use of NanoTherm Therapy in treating brain tumors developed in close partnership with leading experts Prof. Dr. Walter Stummer, PD Dr. Dr. Oliver Grauer, University Hospital Mnster, and PD Dr. Johannes Wlfer, Hufeland Klinikum GmbH Mhlhausen. Targeted towards medical professionals working in the field of neuro-oncology, the training series aims at certifying surgeons in the use of the Company's innovative NanoTherm technology. Two sessions were successfully completed in 2019. In Lublin, Poland, the first treatment center outside Germany, and in Zwickau, another NanoTherm therapy center in Germany, the Parcelsus Clinic, were opened.

These achievements already led to enormously increased corporate sales in the first quarter of 2020. MagForce continues to successfully drive forward its European roll-out strategy in the current fiscal year.

USA: High medical need for a new less invasive, effective and well-tolerated treatment option for prostate cancer in the USA

In 2019, MagForce USA, Inc. successfully completed the first stage of its pivotal clinical US study for the focal ablation of intermediate risk prostate cancer. During this Stage 1 a standardized clinical procedure was validated and developed: MagForce USA had to develop a new procedure by which the NanoTherm is placed in a clinical targeted volume (CTV) of less than 2 to 4cc of volume in the human prostate and provides for a true focal ablation therapy. By modifying the thixotopic nature of the NanoTherm, an increase in viscosity of 100 times was achieved, which allowed NanoTherm to remain at the reverse biopsy instillation site and allow time for the NanoTherm conjugation to occur stabilizing the NanoTherm particles in the CTV. Initial findings showed only minimal treatment related side effects, which were tolerable and similar to those commonly associated with biopsies. The ablation analysis showed very well-defined ablation and cell death in the region of the nanoparticle deposit as it was observed with the previous pre-clinical studies.

The purpose of this focal ablation registration study, which will enroll up to 120 men in a single arm study, is to demonstrate that NanoTherm therapy can focally ablate cancer lesions with minimal side effects for patients who have progressed to intermediate risk prostate cancer stage and are under active surveillance. By destroying these cancer lesions, it is anticipated that patients will be able to remain in Active Surveillance Programs and avoid definitive therapies such as surgery or whole gland radiation with their well-known side effects as long as possible.

In April 2020 the FDA approved a streamlined trial protocol, for the next stage of the Company's pivotal U.S. study with the NanoTherm therapy system for the focal ablation of intermediate risk prostate cancer . The next stage of the clinical trial is being initiated with three well-respected urological centers in Texas, Washington and Florida who actively enrolled patients in Stage 1. In the meantime first patients were enrolled and MagForce is starting treatments.

Results of operations, net assets and financial position

In the financial year, revenues amounted to EUR 840 thousand (previous year: EUR 67 thousand). Revenues were generated from the commercial treatment of patients with NanoTherm therapy in Germany in the amount of EUR 47 thousand (previous year: EUR 66 thousand) and NanoTherm deliveries to subsidiaries in the amount of EUR 793 thousand (previous year: EUR 0 thousand).

Other operating income amounted to EUR 904 thousand. While the previous year was dominated by the extraordinary effect of the intra-group transfer of shares in MagForce USA Inc., which resulted in the realization of hidden reserves in the amount of EUR 13,895 thousand, there was no further transfer of shares in 2019. Consequently, other operating income decreased from EUR 14,909 thousand by EUR 14,005 thousand compared to previous year. Other operating income mainly consists of costs recharged to subsidiaries for management services and other administrative services in the amount of EUR 545 thousand (previous year: EUR 561 thousand), the reversal of provisions in the amount of EUR 173 thousand (previous year: EUR 293 thousand), exchange rate differences in the amount of EUR 75 thousand (previous year: EUR 71 thousand) and income relating to other periods in the amount of EUR 47 thousand (previous year: EUR 7 thousand).

Personnel expenses of EUR 3,987 thousand (previous year: EUR 3,921 thousand) also include bonus payments.

Other operating expenses of EUR 3,371 thousand are EUR 197 thousand higher than in the previous year (EUR 3,174 thousand). The increase in other operating expenses is mainly due to higher impairment losses on interest receivables from the affiliated company MT MedTech Engineering GmbH that is funded by MagForce AG as well as higher patent costs.

While the previous year due to extraordinary effects showed a positive operating result of EUR 6,828 thousand, 2019 closed with a negative operating result of EUR 6,203 thousand. The positive operating result of the previous year is due to the extraordinary effect of the intra-group transfer of shares in MagForce USA Inc. with the realization of hidden reserves in the amount of EUR 13,895 thousand. Normalized for this effect, the Company would have reported a higher negative operating result of EUR 7,067 thousand in the previous year. Interest income of EUR 215 thousand was largely at the same level as in the previous year (EUR 231 thousand), while interest expenses fell by EUR 140 thousand from EUR 1,823 thousand to EUR 1,683 thousand. The reason for the decrease in interest expenses is lower interest on share price linked liabilities. The write-down of the contributions to fund the operations of the subsidiary MT MedTech Engineering GmbH amounted to EUR 1,058 thousand (previous year: EUR 877 thousand). The partially contrary effects resulted overall in only a slight increase in the negative financial result of EUR 58 thousand from EUR 2,468 thousand to EUR 2,526 thousand.

The year 2019 closed with a net loss for the year of EUR 8,731 thousand. The net income of EUR 4,358 thousand in the previous year was due to the extraordinary effect of the intra-group transfer of shares in MagForce USA Inc. with the realization of hidden reserves amounting to EUR 13,895 thousand. Normalized for this effect the previous year ended with a net loss of EUR 9,537 thousand.

Cash flow from operating activities amounted to EUR -5,671 thousand (previous year: EUR - 7,106 thousand). The cash outflow from operating activities was derived indirectly from the net loss for the period. The cash outflows mainly relate to the financing of operating activities.

Cash flow from investing activities amounted to EUR - 1,941 thousand (previous year: EUR - 1,370 thousand) and mainly related to the contributions made in the reporting year to provide financial support for the subsidiary MT MedTech Engineering GmbH as well as the construction of mobile NanoActivator therapy centers and the expenses for the preparation of the technical documentation of the MagForce products.

Cash flow from financing activities amounted to EUR 6,286 thousand (previous year: EUR 9,304 thousand) and is mainly attributable to the proceeds from the capital increase and the stock options exercised. The payments were offset by cash outflows in the form of interest payments.

At the end of the year, the freely available liquidity amounted to EUR 167 thousand (previous year: EUR 1,494 thousand.

Outlook and financial prognosis of 2020

For the year 2020, the following focal points are planned for the Company's development:

In Europe: Increase in the number of commercially treated patients in Poland and Germany, initiation of further placements of NanoActivator devices in Germany and other European countries for the treatment of brain tumors, and the establishment of an efficient reimbursement procedure in Germany and the target countries for NanoTherm therapy in combination with surgery, radiation or chemotherapy as well as continuation and establishment of the "NanoTherm Therapy School" as application training for the use of NanoTherm therapy with the aim of certifying surgeons using the innovative NanoTherm technology.

In the USA: Conducting the second stage of the pivotal trial of NanoTherm therapy in the indication prostate cancer for the territory of the USA by the subsidiary MagForce USA, Inc., preparations for the commercialization of NanoTherm therapy for the treatment of prostate cancer in the USA. Further the completion of the development of an ambulatory NanoActivator device for the focal treatment of prostate cancer.

The impact of the outbreak of the corona pandemic on the future core activities described above cannot be predicted in detail at this time.

Financial outlook

The Company expects a significant increase in the number of patients treated in both Germany and Poland in the financial year 2020, which will have a positive effect on earnings.

MagForce expects an increase in production volumes of NanoTherm to supply the US subsidiary due to the continuation of its pivotal trial and preparations for commercialization in the USA, as well as for the treatment of patients in Germany and Poland. The production of NanoActivator ambulatory devices will take place depending on the progress of the prostate study in the USA.

The expected revenues will not be able to compensate the expenses due to the continuation of the expansion strategy and the associated initiation of treatment series to obtain reimbursement as well as the necessary expansion of commercialization activities, so that a significant operating loss is also expected for the financial year 2020.

Management expects higher debt financing of the business activities and an associated increase in the negative financial result, provided that there are no significant opposing effects from share price linked debt components.

On June 24, 2020 MagForce signed an agreement with U.S. investment firm Yorkville Advisors Global LP for a growth financing via convertible notes of up to EUR 15 million to be drawn in probably up to five tranches. The first tranche of EUR 2.5 million each is expected to be drawn shortly. This financing enables MagForce to further implement its commercial strategy and support the roll-out of its NanoTherm Therapy treatment system.

It can be assumed that the corona pandemic will affect our forecasts, the exact scope of which cannot be estimated at this time.

About MagForce AG and MagForce USA, Inc.MagForce AG, listed in the Scale segment of the Frankfurt Stock Exchange (MF6, ISIN: DE000A0HGQF5), together with its subsidiary MagForce USA, Inc., is a leading medical device company in the field of nanomedicine focused on oncology. The Group's proprietary NanoTherm(R) therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles.

NanoTherm(R), NanoPlan(R), and NanoActivator(R) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan, and NanoActivator are trademarks of MagForce AG in selected countries.

For more information, please visit: http://www.magforce.com. Get to know our Technology: video (You Tube)Stay informed and subscribe to our mailing list.

Disclaimer

This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.

Contact:Barbara von FrankenbergVice PresidentCommunications & Investor RelationsT +49-30-308380-77E-Mail: bfrankenberg@magforce.com

30.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at http://www.dgap.de

Read more:
MagForce : Publishes Financial Results for the Year 2019 and Operative Highlights - Marketscreener.com

Nanobiotix: Publication of the 2019 Universal Registration Document – Business Wire

Posted on by

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205 the Company), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the publication of its universal registration document for the financial year ended December 31, 2019. This document has been approved by the French financial market authority (Autorit des marchs financiers or AMF) on May 12, 2020 under the number R.20-010.

This document is available on Nanobiotixs website on https://www.nanobiotix.com/regulated-information/ and on the AMF website on (www.amf-france.org).

The 2019 universal registration document includes:

- the 2019 financial annual report,- the management report, including the information and the report on corporate governance,- The reports from the Companys statutory auditors and information related to their fees, and- The required information in relation to the Companys share buy-back program

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany. The Company also possesses an affiliate, Curadigm, located in Paris, France as well as, through an affiliate, in Cambridge, MA in the U.S.

DisclaimerThis press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the universal registration document of Nanobiotix approved by the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.20-018 on May 12, 2020 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

See the original post here:
Nanobiotix: Publication of the 2019 Universal Registration Document - Business Wire

Global Healthcare Nanotechnology Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2026 – Cole of Duty

Posted on by

Released by MarketsandResearch.biz, Global Healthcare Nanotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2026 profoundly explores an overarching research study which talks about the current market scenario. The report explains the overall global Healthcare Nanotechnology market journey in the previous five years along with the prophecy made by the experts in the industry. The report attributes product innovation, and technological advancements boosting market development in the near future. A comprehensive study of key market dynamics and current trends, along with relevant market sectors and sub-sectors is offered. The report incorporates important factors such as market opportunities, risk, benefit, opportunity, loss, and profit.

Market Overview:

Data associated with the market on the products, strategies and market share of leading companies of this market are mentioned. Detailed understandings into ongoing industry trends, trend prediction, and growth drivers are offered in the report. Additionally, potential market risks, obstacles, threats, and uncertainties are also determined in the report. Market segments examined in the report include major types, applications, regions, and end-users. This research study features the data about the global Healthcare Nanotechnology market share held by every region with potential growth prospects on the basis of the regional analysis. The research document serves accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/41102

Competitive rivalry scenario for the global Healthcare Nanotechnology market: Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International,

The study broadly exemplifies, the regional hierarchy of this market, while categorizing the same into: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into: Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other

On the basis of application, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into: Anticancer, CNS Product, Anti-infective, Other,

Drivers & Challenges:

The market report delivers information about the driving factors affecting the revenue scale of this global Healthcare Nanotechnology industry as well as their influence on the commercialization graph of this business sphere. The research study incorporates the latest trends building up the market in conjunction with the challenges that this business vertical will face over the forecast duration. Additionally, it encompasses the obstacles that this industry will be characterized by, in the forecast timeframe.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/41102/global-healthcare-nanotechnology-market-2020-by-company-regions-type-and-application-forecast-to-2026

Report Answers Following Questions:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

Read more from the original source:
Global Healthcare Nanotechnology Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2026 - Cole of Duty

Coronavirus (COVID-19) Impact On Global Nanorobots Market 2020 Analysis By Top Key Players Bruker, Jeol, Thermo Fisher, Ginkgo Bioworks, Oxford…

Posted on by

The research report on theNanorobots marketis a specialized and in-depth industry research dealing with all technical and profitable business outlook. In the dossier all the historical and current trends of Nanorobots market is discussed comprehensively. It also showcases the trends that are anticipated for the Nanorobots market during the forecast period.

The industry statistics that are encompassed within this report is not only global but also deals with regional and country analysis. This helps the user acquire an extensive perspective about the Nanorobots market. The statistical data that is provided is further supported with thorough qualitative information. The aspects that directly or indirectly impact the Nanorobots market are exemplified through attributes such as drivers, restraints, opportunities, and the market challenges.

FREE Request Sample is Available@https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html#request-sample

The research study encompasses all the trusted models and industry analysis which prove useful for the market players to plan out the business strategies that will further help for the market development. The report also offers exhaustive competitive landscape of the market players. The major market players that are incorporated within this report areBruker, Jeol, Thermo Fisher, Ginkgo Bioworks, Oxford Instruments, Ev Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract, Nanonics Imaging, Novascan Technologies, Angstrom Advanced, Hummingbird Scientific, Nt-Mdt Spectrum Instruments, Witec.

The market segments that are included in the report are{Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based}; {Nanomedicine, Biomedical}. Along with major segments the sub-segments of the Nanorobots market is also included. The regional segmentation of the market includes North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The major countries that are included are US, Canada, Germany, UK, China, Japan, Brazil, Mexico, among others. The study evaluates the dominance of the market in each region which helps the clients to evaluate the market demand and share on the global platform.

Read Detailed Index of full Research Study at::https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html

Details about the market players are profiled at the end. It includes all the minute information about the organization such as its headquarter location, the sales and the production details, recent product developments, and the company strategies.

Main market perceptions consist of the following:

1. The survey of Nanorobots delivers market size and growth rate for the forecast period 2020-2026.

2. It presents detailed understandings into ongoing industry trends, trend prediction, and growth drivers about the Nanorobots.

3. It offers an independent review of market sectors and the regional outlook of Nanorobots.

4. The report provides a detailed overview of the supplier landscape, combative analysis, and key market strategies to gain an advantage on competing companies.

For Any Query Regarding the Nanorobots Market Report? Contact Us at:https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html#inquiry-for-buying

Go here to see the original:
Coronavirus (COVID-19) Impact On Global Nanorobots Market 2020 Analysis By Top Key Players Bruker, Jeol, Thermo Fisher, Ginkgo Bioworks, Oxford...

Recent Progress and Future Directions: The Nano-Drug Delivery System f | IJN – Dove Medical Press

Posted on by

Ming-Chen Sun,1,* Xiao-Ling Xu,1,* Xue-Fang Lou,2 Yong-Zhong Du1

1Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Peoples Republic of China; 2School of Medicine, Zhejiang University City College, Hangzhou 310015, Peoples Republic of China

*These authors contributed equally to this work

Correspondence: Yong-Zhong DuInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yu-Hang-Tang Road, Hangzhou 310058, Peoples Republic of ChinaTel +86-571-88208435Fax +86-571-88208439Email duyongzhong@zju.edu.cnXue-Fang LouSchool of Medicine, Zhejiang University City College, 51 Hu-Zhou Street, Hangzhou 310015, Peoples Republic of ChinaTel +86-571-88013011Fax +86-571-88018442Email louxf@zucc.edu.cn

Abstract: Vitiligo is a depigmentation disease that seriously affects the physical health, mental health and quality of life of a patient. Therapeutic aim at control immunoreaction by relieving oxidative stress. Unfortunately, the cuticle barrier function and lack of specific accumulation lead to unsatisfactory therapeutic outcomes and side effects. The introduction and innovation of nanotechnology offers inspiration and clues for the development of new strategies to treat vitiligo. However, not many studies have been done to interrogate how nanotechnology can be used for vitiligo treatment. In this review, we summarize and analyze recent studies involving nano-drug delivery systems for the treatment of vitiligo, with a special emphasis on liposomes, niosomes, nanohydrogel and nanoparticles. These studies made significant progress by either increasing drug loading efficiency or enhancing penetration. Based on these studies, there are three proposed principles for topical nano-drug delivery systems treatment of vitiligo including the promotion of transdermal penetration, enhancement of drug retention and facilitation of melanin regeneration. The presentation of these ideas may provide inspirations for the future development of topical drug delivery systems that will conquer vitiligo.

Keywords: vitiligo, nano-drug delivery system, transdermal penetration, liposomes, skin

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Go here to see the original:
Recent Progress and Future Directions: The Nano-Drug Delivery System f | IJN - Dove Medical Press

Biologic Therapeutics Market Dynamics, Segments, Size and Demand, 2017 2025 – Cole of Duty

Posted on by

Global Biologic Therapeutics Market: Snapshot

The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all over the world.

Know the Growth Opportunities in Emerging Markets

The global biological therapeutics market mainly comprises of derivatives extracted from whole blood and other blood components, organs and tissue transplants, stem cell therapy, human breast milk, fecal microbiota, human reproductive cells, and antibodies. Several biological materials could are also extracted from other animals.

The global biological therapeutics market not only deals with extracted biologic materials from the market, but also involves providing treatments based on the use of these materials. Most biologic therapeutic substance include individual components such as thrombolytic agents, interferons, monoclonal antibodies, additional products, interleukin-based products, haematopoietic growth factors, hormones, and therapeutic enzymes. Materials used for producing biopharmaceuticals might also be derived from recombinant E. coli or yeast cultures, mammalian cell cultures, plant cell cultures, and mosses.

The global biologic therapeutics market is boosted through the presence of cancer, diabetes, and another coronary heart diseases. A growing geriatric population also has been responsible for making the market gain extensive revenue in the form of quality treatment processes. However, the market might be restrained due to high cost of extraction of the biologic materials. Nevertheless, extensive research and development carried out by many businesses in this market might offset the restraints substantially.

Global Biologic Therapeutics Market: Overview

The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions.

Global Biologic Therapeutics Market: Key Trends and Opportunities

First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.

Increasing prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and a growing geriatric population are some other factors contributing to the biologic therapeutics market. In addition, mounting clinical trials and innovative research and development practices to develop novel drugs is boosting the growth of biologic therapeutics market.

On the flip side, manufacturing difficulties due to complexities of drug molecules is challenging the growth of biologic therapeutics market. Nevertheless, increasing research and development in the pharmaceutical sector and rising applications of biologics is anticipated to provide new opportunities to this market.

Global Biologic Therapeutics Market: Market Potential

The Genetic Technology module for TechVision Opportunity Engine provides the most recent R&D advancements and developments while looking into opportunities for profit in the exploding genetic technology field via joint ventures, acquisitions, and technology transfer. The entire range of genetic technology applications covered in the module includes latest developments in omics technologies, which include genetic, cellular, and alternative therapies; genetically modified plants and animals, and sequencing technologies.

The health and wellness cluster of genetic technology techvision opportunity engine looks into developments across several areas, which include genetic engineering, drug discovery and development, regenerative medicine, cosmetic procedures, nanomedicine, drug delivery, smart healthcare, pain and disease management, and personalized medicine.

Order this Report TOC for Detailed Statistics

Global Biologic Therapeutics Market: Geographical Outlook

As per the reports analysis, the worldwide biologic therapeutics market could see a classification into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America, among them, could secure a leading position due to a robust research infrastructure and presence of expert researchers and scientists for biotechnology research. Europe is a key market for biologic therapeutics due to high level of biotechnology research and pioneering research in the field of biotechnology. Asia Pacific is likely to emerge as a significant market for biologic therapeutics with increasing advancement in biotechnology research.

Global Biologic Therapeutics Market: Competitive Landscape

The worldwide biologic therapeutics market is predicted to witness the prominence of several key players, namely Pfizer Inc., Novartis Global, Smith Medical, Concord Biotech, H. Lundbeck A/S, AstraZeneca, Merck & Co. Inc., GlaxoSmithKline plc, Aurobindo Pharma Ltd., and Retractable Technologies Inc. Market players could resort to common business strategies, viz. product innovation, cutting-edge developments, and acquisitions to push up growth in the market.

Read more here:
Biologic Therapeutics Market Dynamics, Segments, Size and Demand, 2017 2025 - Cole of Duty

Global Healthcare Nanotechnology Market Trends, Applications, Competitive Strategies and Future Outlook 2025. – Cole of Duty

Posted on by

The recently published market study by GLOBAL MARKETERS.BIZ highlights the current trends that are expected to influence the dynamics of the Healthcare Nanotechnology market in the upcoming years. The report introspect the supply chain, cost structure, and recent developments pertaining to the Healthcare Nanotechnology market in the report and the impact of the COVID-19 on these facets of the market. Further, the micro and macro-economic factors that are likely to impact the growth of the Healthcare Nanotechnology market are thoroughly studied in the presented market study.

Get PDF Samplecopy(including TOC, Tables, and Figures) @https://www.globalmarketers.biz/report/medicine/global-healthcare-nanotechnology-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130533#request_sample

Leading Players Are :

AmgenTeva PharmaceuticalsAbbottUCBRocheCelgeneSanofiMerck & CoBiogenStrykerGilead SciencesPfizer3M CompanyJohnson & JohnsonSmith & NephewLeadiant BiosciencesKyowa Hakko KirinShireIpsenEndo International

Reasons to Trust Our Business Insights

Proven track record of delivering high-quality and insightful market studies

Data collected from credible sources including product managers, sales representatives, marketing executives, and more

Providing accurate insights for over ten industrial verticals

Swift delivery of reports with COVID-19 impact without any delays

Up-to-date market research and analytical tools used to curate market reports

Critical Data in the Healthcare Nanotechnology Market Report

Company share analysis and competition landscape

Recent trends and notable developments in the Healthcare Nanotechnology market space

Growth projections of each market segment and sub-segment during the forecast period

COVID-19 impact on the global Healthcare Nanotechnology market

Recent innovations, product launches, and technological advances relevant to the Healthcare Nanotechnology market

Regional Assessment

The regional assessment chapter in the report offers an out and out understanding of the potential growth of the Healthcare Nanotechnology market across various geographies such as:

Application Assessment

The presented study ponders over the numerous applications of the Healthcare Nanotechnology and offers a fair assessment of the supply-demand ratio of each application including:

Market Taxonomy

By Type

NanomedicineNano Medical DevicesNano DiagnosisOther

By Application

AnticancerCNS ProductAnti-infectiveOther

Enquire Here For Customization:

https://www.globalmarketers.biz/inquiry/customization/130533

By Region

North America

Latin America

Europe

China

Japan

SEA and Other APAC

MEA

Get Table of Contents with Charts, Figures & Tables https://www.globalmarketers.biz/report/medicine/global-healthcare-nanotechnology-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130533#table_of_contents

The report resolves the following doubts related to the Healthcare Nanotechnology market:

1. Who are the leading market players operating in the current Healthcare Nanotechnology market landscape?

2. Which region is expected to dominate the Healthcare Nanotechnology market in terms of market share and size during the forecast period?

3. What are the various factors that are likely to contribute to the growth of the Healthcare Nanotechnology market in the upcoming years?

4. What is the most impactful marketing strategy adopted by players in the Healthcare Nanotechnology market?

5. What is the projected CAGR growth of application 1 during the forecast period?

See the rest here:
Global Healthcare Nanotechnology Market Trends, Applications, Competitive Strategies and Future Outlook 2025. - Cole of Duty

Does the dusk of old-school antibiotics mean the dawn of antimicrobial nanomaterials? – Advanced Science News

Posted on by

Share

Share

Email

The research and development of antibiotics has been intense since their discovery in the early part of the past century.

However, in the last decade, there has been a dramatic shift in their effectiveness. More and more bacterial strains have developed resistance to antibiotics, and these resistant microorganisms are able to withstand the activity of commonly used antimicrobial drugs in a way that standard treatment becomes ineffective and infections persist. This increases the risk of their spread, which is clearly seen in clinical practice supported by World Health Organization annual reports.

The development of resistant strains is a natural phenomenon that occurs through selective pressure on the population of microorganisms. It is no surprise, then, that there is a general increase in the number of resistant microorganisms all around the world, although specific patterns vary considerably across countries.

Nanomaterials include a variable range of colloidal nanoparticles not only in terms of chemical composition but also in terms of shape and size, which significantly affect the desired properties their effect and biocompatibility, in particular. These properties can be customized during or after the preparation of nanoparticles according to the intended application.

Basic research includes the study of the relationship between morphology and physico-chemical and biological properties of nanomaterials, which form the theoretical basis for the design and synthesis of new generations of nanomaterials having specific applications in medicine. Due to their dimensions, nanoparticles are getting close to their target biological entities.

Current research in the field of nanomedicine focuses primarily on the rational transport of diagnostic and therapeutic agents to eliminate side effects and precisely target the desired location in the organism. Applications are not only available in human medicine but also in veterinary medicine and agriculture.

Dr. Smerkova and her colleagues from Mendel University in Brno, Czech Republic, have recently discussed current trends in the synthesis, development, and applications of advanced nanomaterials as alternatives to antibiotics. Although the active targeting of pathogens is a relatively emerging area, it has the potential to provide many benefits, including the improvement of therapeutic outcomes due to selectively targeting pathogens while sparing the human microbiome.

These aspects are inevitably associated with decreased side effects and reduction of socio-economical losses, and thus represent the golden grail of antibacterial treatment.

Besides these primary impacts, the fight against bacterial biofilm formation represents an important challenge for targeting strategies. The nanoparticles unique physicochemical properties allow them enhanced penetration through biofilm and to kill shielded bacteria by direct contact with intrinsic antibacterial nanomaterial or by antimicrobials delivery, explained Dr. Smerkova.

The targeting of intracellular pathogens surviving in hijacked macrophages is another special assignment of antimicrobial nanoparticles or nanocarriers loaded with antibiotics. On the other hand, due to their multicomponent and complex nature, actively targeted nanoparticles require a comprehensive understanding of their in-vivo stability, possible off-target effects, or loss of targeting ability due to protein corona formation and intracellular and organismal fate.

Dr. Smerkova also stated: For further acceleration of the development in the field of efficient targeting ligands for antibacterial nanoparticles, detailed knowledge of pathogen-specific surface structures needs to be gathered. In addition, high-throughput methods capable of screening for similarities with surface structures of common or uncommon members of the microbiome to achieve maximal selectivity are of an utmost interest.

Since science is experiencing the advent of superfast computational units capable of such screenings, it can be expected that virtual screening software will pave the way for novel targeting ligands based on a broad spectrum of various biomolecules. This would be a major leap forward and towards ligands that help generate an inexhaustible spectrum of novel antibacterial nanomaterials that could be used to combat the global threat posed by antibiotic-resistant bacteria.

Article written by Kristyna Smerkova, Kristyna Dolezelikova, Lucie Bozdechova, Zbynek Heger, Ludek Zurek, and Vojtech Adam

Reference: Kristyna Smerkova et al. Nanomaterials with active targeting as advanced antimicrobials. WIREs Nanomedicine and Nanobiotechnology (2020). DOI: 10.1002/wnan.1636

View post:
Does the dusk of old-school antibiotics mean the dawn of antimicrobial nanomaterials? - Advanced Science News

The future of medicine – Switzer Financial News

Posted on by

It is my opinion that over the next 5 to 10 years the delivery of medicine will change dramatically. The pharmacist of the future will become the pharmacist of the past. Many years ago, before the incredible sophistication of the pharmaceutical industry, many pharmacists compounded medications in their own facility.

I foresee a situation where a person will go to the doctor following a full assessment of their own genome. A treatment plan will be formulated based on the persons own genetic abnormalities and predispositions. Rather than taking a number of separate pharmaceutical pills and, for those so inclined, vitamin supplements, the doctor will administer a personalised prescription for the person. This will be taken to their pharmacist and, using nanotechnology, all of these therapies will be delivered within the one small pill, taken once daily.

The technology would be advanced to the point where each separate medication within the nano-pill would be released at the appropriate time into the circulation. We are well aware that computer technology power doubles every 18 months and the advances in nanotechnology appear to be mirroring this.

On a separate, but similar, note, the University of Pittsburgh has released recently in the Journal of Investigative Dermatology, a fingertip patch with 400 microneedles for vaccine delivery for live or attenuated vaccines.

The microneedles are made from three-dimensional sugar structures incorporated into what is known as a multicomponent dissolving microneedle array. Interestingly, this not only induces an antibody response but also improves the cellular response better than standard vaccines given via injection. It appears from the preliminary studies that this will induce a strong and long-lasting immunity. The researchers trialled this in mice administering a live adenovirus with encoded antigens and a specific immune stimulant to enhance the local immune response.

In the last few weeks, researchers at the University of Oxford in England have started a trial of a vaccine for the Coronavirus. It may be that, in the very near future, rather than the needle jab, we are using these micro patches instead for all vaccines.

Researchers from Harvard University in the USA are also working on a similar patch technology for the management of diabetes. The patch not only delivers insulin through the skin but also measures real-time blood sugar levels.

At present, the vast majority of insulin-dependent diabetics need to constantly prick their fingers to monitor blood sugar levels and then inject themselves on multiple occasions throughout the day. Again, over the next few years, the management of diabetes will be revolutionised by the use of these micro patches.

For many chronic conditions affecting millions of people, especially over the age of 50, the future of chronic medical management is very bright. When I started medical school in the 1970s, our medical and surgical therapies were modestly effective and I have seen a revolution in the management of chronic illnesses, such as cardiovascular disease and cancer, over the past 40 to 50 years.

With these extraordinary advances mentioned above, which are only a portion of what we will see over the next decade, the future of medicine is looking very bright indeed.

Read more from the original source:
The future of medicine - Switzer Financial News

Healthcare Nanotechnology (Nanomedicine) Market 2020 | Growth Drivers, Challenges, Trends, Market Dynamics and Forecast to 2026 – Cole of Duty

Posted on by

Endo International

The scope of the Report:

The report analyzes the key opportunities, CAGR, and Y-o-Y growth rates to allow readers to understand all the qualitative and quantitative aspects of the Healthcare Nanotechnology (Nanomedicine) market. A competition analysis is imperative in the Healthcare Nanotechnology (Nanomedicine) market and the competition landscape serves this objective. A wide company overview, financials, recent developments, and long and short-term strategies adopted are par for the course. Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in the sales of Healthcare Nanotechnology (Nanomedicine) across the world has been calculated through primary and secondary research. The Healthcare Nanotechnology (Nanomedicine) Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=NYH&utm_medium=888

Highlights of the Healthcare Nanotechnology (Nanomedicine) market study:

Speculations for sales:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Healthcare Nanotechnology (Nanomedicine) market. Additionally, it includes a share of every segment of the Healthcare Nanotechnology (Nanomedicine) market, giving methodical information about types and applications of the market.

Key point summary of the Healthcare Nanotechnology (Nanomedicine) market report:

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It presents an in-depth analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by creating a pin-point analysis of market segments and by having complete insights of the Healthcare Nanotechnology (Nanomedicine) market.

This report helps users in comprehending the key product segments and their future.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Healthcare Nanotechnology (Nanomedicine) market

Chapter 2: Evaluating the leading manufacturers of the global Healthcare Nanotechnology (Nanomedicine) market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4: Presenting global Healthcare Nanotechnology (Nanomedicine) market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Finally, the report global Healthcare Nanotechnology (Nanomedicine) market describes Healthcare Nanotechnology (Nanomedicine) industry expansion game plan, the Healthcare Nanotechnology (Nanomedicine) industry knowledge supply, appendix, analysis findings and the conclusion. It includes a through explanation of the cutting-edging technologies and investments being made to upgrade the existing ones.

Report customization:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Get Complete Report @ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=NYH&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Healthcare Nanotechnology (Nanomedicine) Market Size, Healthcare Nanotechnology (Nanomedicine) Market Trends, Healthcare Nanotechnology (Nanomedicine) Market Growth, Healthcare Nanotechnology (Nanomedicine) Market Forecast, Healthcare Nanotechnology (Nanomedicine) Market Analysis sarkari result, sarkari exam, sarkari naukri

Our Trending Reports

Offshore AUV and ROV Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Oil & Gas Analytics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the article here:
Healthcare Nanotechnology (Nanomedicine) Market 2020 | Growth Drivers, Challenges, Trends, Market Dynamics and Forecast to 2026 - Cole of Duty

‘Laser tweezers’ in nano lab used in search for drug to prevent COVID-19 replication – The Province

Posted on by

By Nicole Bergot

A drug can prevent the virus responsible for the COVID-19 pandemic from replicating once inside an infected host, say researchers at the University of Alberta now searching for that magic bullet.

We aim to identify drugs that can be tested for effectiveness and safety in future trials, said Michael Woodside, a professor in the department of physics, using $370,700 in emergency funding from the Canadian Institutes of Health Research (CIHR) to find the elusive drug.

The plan is to screen first for drugs that are already approved for human use that could be repurposed to treat COVID-19 more quickly before broadening the search to potential drugs that are not currently approved.

Woodside explains that the genome of the novel coronavirus is made up of ribonucleic acid (RNA), not DNA so once inside an infected host, the virus inserts its RNA genome into the cell causing the creation of proteins the virus needs to replicate. And for all of this to occur, the novel coronavirus uses a process called programmed ribosomal frameshibing (PRF), a topic that Woodside, as a biophysicist, and his lab have been studying for years.

Researchers using laser tweezers to mimic what happens inside an infected cell were able to identify the mechanism through which PRF is triggered and now they can find molecular compounds to stop it from happening.

Most efforts to find drugs look for compounds that target the viral proteins directly, explains Woodside. Whats different about our approach is that we are targeting the virus through its RNA, rather than the proteins.

Woodside, inside the National Research Council of Canadas Nanotechnology Research Centre right here in Edmonton, is working closely with grad students, American counterparts, and Jack Tuszynski, a biophysics professor also in the department of physics, currently on secondment to the department of oncology in the faculty of medicine and dentistry.

Interdisciplinary research and scientific collaborations are essential to stopping the COVID-19 pandemic, said Woodside. Solutions have to engage expertise and approaches across a wide range of areas to understand the biophysics of the viral molecules, the biology of virus replication, the chemistry of drugs and their interactions with targets, the response of the immune system, the symptoms and epidemiology of the disease, and the response of patients to treatments.

Building and validating a model of the viral RNA for drug screening will occur over the next few months, with screening to identify approved drugs to follow before any potential candidates move toward preclinical tests.

Visit link:
'Laser tweezers' in nano lab used in search for drug to prevent COVID-19 replication - The Province

IIT-M develops oil-based cancer therapy – Times of India

Posted on by

Researchers from IIT-Madras have developed a clove oil-based emulsion to treat cancer, claiming that the formulation would have enormous scope in the treatment of undifferentiated cancer and can also overcome anti-microbial resistance. The research papers were published recently in the reputed International Journal of Nanomedicine.The researchers, led by professor R Nagarajan, head, department of chemical engineering in IIT Madras, have developed a nano-scale emulsion of clove bud using the spontaneous self-emulsification technique with potent anti-cancer and antibacterial activity. This formulation meets all compliance requirements, they said. According to Nagarajan, while conventional therapies for cancer like radiation, chemotherapy and surgery cause severe damage to normal cells along with other major side-effects, the plant-based essential oils have paved way to devise innovative solutions to these drawbacks of synthetic drugs.The advantages of these emulsions lie in their small droplet size, ease of preparation, optical clarity, good physical stability, improved bio-availability, non-toxicity and non-irritability, said Nagarajan. This formulation would have an enormous scope in the treatment of metastatic cancer. Moreover, the components involved are cost-effective and demonstrate good efficacy, and the technique employed is simple, which is the utmost need for drug development, he said.The team of scientists includes M Joyce Nirmala, post doctoral fellow, Vineet Gopakumar, B Tech student, and Latha Durai, Research Scientistall from IIT-Madras.

See original here:
IIT-M develops oil-based cancer therapy - Times of India

Nanopharmaceuticals Market: Rise in the Incidence of Chronic Diseases is Expected to Drive the Market – BioSpace

Posted on by

Nanopharmaceuticals Market: Overview

Nanopharmaceuticals are revolutionizing medical science by leveraging nanomedicine to render effective healthcare, especially in developing countries. The technology is yet in evolution stages and promises to bring advancement not only in therapeutics but also in detecting diseases and targets. Also, one factor that is making it popular is its cost-effectiveness.

Read Report Overview - https://www.transparencymarketresearch.com/nanopharmaceuticals-market.html

Rise in the incidence of chronic diseases such as infectious diseases, cancer, and cardiovascular diseases, is paving way for expansion of nano-pharmaceuticals market. Nanopharmaceuticals are also referred to as nanotechnology-based pharmaceuticals. The advancement is becoming an integral part of medical science and has potential to treat diseases at cellular level.

Primarily, nanopharmaceuticals are particles in the size range 10 to 1,000 nanometers of specific matter used to manufacture drugs. As a result of composition and shape, the medicines have several benefits to offer over the normal medicines.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66464

The report on nanopharmaceuticals market offers insights about the latest developments in the field. Besides, it targets the potential drivers which will help in the expansion of the market in the tenure of forecast period. Later, the market intelligence offers details about particular segments dominating in specific regions.

Nano-pharmaceuticals Market: Trends and Opportunities

Increase in the incidence of chronic diseases such as cancer, infectious diseases, and cardiovascular diseases, is one of the main factors fuelling nano-pharmaceuticals market. Prominent players in the nano-pharmaceuticals market are investing on large scale in order to introduce improved medicines in the market.

Request for Analysis of COVID-19 Impact on Nano-pharmaceuticals Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66464

The advancements in the nanopharmaceuticals are likely to address therapeutics for critical diseases, which are yet to be explored. This can be explained by an example of Jazz Pharmaceuticals, a key player of nano-pharmaceuticals market. In August 2017, the company received FDA approval for Vyxeos. Vyxeos is basically used for the treatment of acute myeloid leukemia.

Registering the pace of research and developments underway for nanopharmaceuticals, global nano-pharmaceuticals market is projected to grow at a significant pace in the course of the forecast period.

On the other side, factors such as less solubility of nano-pharmaceuticals, toxicity issues, and its functioning need to be addressed on a wider scale. If not, these factors may hinder the growth of the nanopharmaceutical market in the tenure of forecast period.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=66464

Nanopharmaceuticals Market: Regional Outlook

As a result of substantial advancement in the research and development activities in North America, the region is expected to dominate in the global nano-pharmaceuticals market. Besides, the region is witnessing rapid adoption rate of nano-pharmaceuticals for advanced therapeutics. Also, presence of prominent players is another main factor which is fuelling the expansion of nano-pharmaceutical market.

Due to presence of large number of players in the nano-pharmaceuticals market, the competition is also intense. These players are bringing several strategies and developments in the market to gain foothold in the market. Prominent players are expanding their reign by acquisitions, merging and collaborations. Some of the prominent players in the market are- Teva Pharmaceuticals Industries Limited, JOHNSON & JOHNSON, Shire Plc., Novartis AG, Hoffmann-La Roche AG, Pfizer Inc., Merck & Co., and Sanofi S.A.

Pre Book Nano-pharmaceuticals Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=66464&ltype=S

Nano-pharmaceuticals Market: Competitive Analysis

Some of the key players in the nanopharmaceuticals market are JOHNSON & JOHNSON, Sanofi S.A, Hoffmann-La Roche AG, Teva Pharmaceuticals Industries Limited, Novartis AG, Merck & Co., Shire Plc., and Pfizer.

Browse more Trending Reports by Transparency Market Research:

Medical Animation Market: https://www.transparencymarketresearch.com/medical-animation-market.html

Chiropractic Care Market: https://www.transparencymarketresearch.com/chiropractic-care-market.html

Proton Therapy Market: https://www.transparencymarketresearch.com/proton-therapy-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Read the original post:
Nanopharmaceuticals Market: Rise in the Incidence of Chronic Diseases is Expected to Drive the Market - BioSpace

The World on its Knees – Daijiworld.com

Posted on by

April 14, 2020

Predictions about the disasters are useless, unless someone take a note of such predictions beforehand and be well prepared for the devastation or more effectively, prevent them from happening.

Yuval Noah Hariri is the celebrity author of the popular science bestsellers Sapiens: A Brief History of Humankind (2014), Homo Deus: A Brief History of Tomorrow (2016), and 21 Lessons for the 21st Century (2018).

In Sapiens he surveys the entire length of human history, from the evolution of Homo sapiens about 70000 years ago along with other human like species Homo neanderthals and Homo erectus, the development of their cognitive abilities, up to the political and technological revolutions of the 21st century.

Where as in Homo Deus he is examining possibilities of the future of Homo sapiens. The book's premise outlines that, in the future, humanity is likely to make a significant attempt to gain happiness, immortality and God-like powers. The book goes on to openly speculate various ways this ambition might be realised for Homo sapiens in the future based on the past and present. He predicts the possible consequences of a futuristic biotechnological world in which intelligent biological organisms are surpassed by their own creations. He speculate that we as a species will mutate ourselves into new God-like species, Homo Deus.

And we all believed that with its technological advancements in the fields of artificial intelligence (AI), bio technology and nano technology, human race is going to achieve that in the near future.

The scientific advancements in the field of AI predicted that by the year 2040, we would achieve technological singularity. Intelligence explosion, in which an upgradable intelligent agent will eventually enter a "runaway reaction" of self-improvement cycles, with each new and more intelligent generation appearing more and more rapidly, causing an 'explosion' in intelligence and resulting in a powerful superintelligence that may achieve self-awareness and qualitatively far surpasses all human intelligence.

The advancements in the field of medicines, bio technology and nano technology predicted that the death will be optional for us by the year 2040.

Advancements in space science and technology predicted that we will be capable of colonizing Moon, Mars and beyond.

We believed we have the best of the political systems governing the different parts of the world. Every system, be its communist, democratic, imperialistic or some other, boasted its own superiority over the other and claimed to be the best equipped to manage its population to the best of its knowledge. Most advanced countries boasted the best of the medical facilities that equipped to face any kind of medical problems, and ridiculed the others, the less privileged.

Our Gods and religious systems did not stay behind in this race and claimed the solutions to the each of the problems faced by the humanity and offered answers to the questions of our existence and purpose. Every God, every religion claimed its supremacy over the other and we did not hesitate to kill each other in the very name of the Gods supposed to protect and bring peace to humanity.

Then it hit us

Its not even a living thing. Just a few RNA (Ribonucleic Acid) strands covered with a protein sheath, so small that normal microscopes cant see it. It was there all along, but novel because of its new avatar or strain. It requires a living cell to start its activities and all it does is replicate itself. Nevertheless, in this process, it created havoc and chaos and succeeded to bring down the whole, mighty world down on its knees without any discrimination. The powerful, highly developed nations, their poor counterparts, democratic, communist or imperialistic, it treated them all the same. It did not see the religion, language, qualification, financial status, economical background or the geographical location and easily be termed as a great equalizer.

Yes, novel coronavirus.

We had several warnings. We had so many pandemics those wiped off millions of lives in the history. Apart from that, Bill Gates and former US President George W Bush and many others scientists and visionaries have warned well in advance about such out breaks and suggested the ways to be prepared.

There are few pictures and videos in social media going viral now about some books and movies, which predicted about the pandemics.

Funny thing about such predictions, including that of the famous Nostradamus are that they all surface after the event and everyone jumps into the bandwagon to say, Look, I told you so.

Predictions about the disasters are useless, unless someone take a note of such predictions beforehand and be well prepared for the devastation or more effectively, prevent them from happening.

Interestingly, in his latest book 21 Lessons for the 21st Century, Yuval Noah Hariri discusses about challenges and possible solutions for 21 different things like Work, Liberty, Equality, Religion, Immigration, Terrorism etc., but misses a Health Pandemic.

Our Gods, religious, political, technological and medical systems did not know what hit them. Its proved beyond doubt that all Gods and religious systems, all kinds of political systems, scientific advancements have failed in their current avatars and they are not equipped to face a pandemic of this kind.

There is not a solution in the horizon. We have not reached a plateau as of today and the number of positive cases and deaths are steadily rising all over the world. Moreover, nobody knows for sure if there will be a solution and if at all, when.

And if we survive this pandemic, and I dont know how many would survive, the world as we know will change. A change like never seen before. However, a change thats the need of the hour.

The survivors of this new world order need to sit together and retrospect about the way we ran our world so far. They should determine if they need Gods and Religions, and if yes, in which format? They need to revamp all the political, technological, economical and medical systems in their current avatars and design totally new effective systems which are well equipped to run the world in a just and fair way.

A new world that gives every human being an equal opportunity of existence and well-being.

The Risen Ape is yet to find its ground in the larger schemes of things.

Read more here:
The World on its Knees - Daijiworld.com

Homemade masks made of silk and cotton may boost protection – UChicago News

Posted on by

The experiments took place in two plexiglass boxes connected by a tube. In one chamber, the team created a cloud of particles and blew them toward the tube, which was covered by different combinations of cloth. Mike Schmoldt and Greg Moss, environmental safety experts at Argonne who specialize in respirator testing and the effects of aerosol particles, used laboratory-grade scientific instruments to measured the number and size of particles in the chambers before and after passing through the fabric.

According to their results, one layer of a tightly woven cotton sheet, combined with two layers of polyester-based chiffona sheer fabric often used in evening gownsfiltered out the most aerosol particles (80% to 99%, depending on particle size). Substituting the chiffon with natural silk or a polyester-cotton flannel, or simply using a cotton quilt with cotton-polyester batting, produced similar results.

Though the study does not attempt to replicate real-world conditions, the findings are a useful guide. The researchers pointed out that tightly woven fabrics, such as cotton, can act as a mechanical barrier to particles; whereas fabrics that hold a static charge, like certain types of chiffon and natural silk, can serve as an electrostatic barrier. The electrostatic effect serves to suck in and hold the tiniest particles, which might otherwise slip through holes in the cotton. This is key to how N95 masks are constructed.

However, Guha added, even a small gap reduced the filtering efficiency of all masks by half or more, emphasizing the importance of a properly fitted mask.

Fabrics that did not do well included standard polyester and spandex with more open weave. In general, Guha said, fabric with tighter weaveswith fewer gaps between the strands of yarnworked better.

This is some of the first methodical data Ive seen on homemade masks. Its very helpful to have some idea of how the different types of fabric perform, said Emily Landon, executive medical director of infection prevention and control at the University of Chicago Medicine. I was also pleasantly surprised by how effective some of the homemade masks can be in the right conditions.

Landon noted that the advice to wear homemade masks while out in public is intended primarily to protect others from your own respiratory droplets, and that universal adoption of this recommendation will go a long way to make everyone safer.

In that case, any mask is better than none.

The first author on the study was Abhiteja Konda with Argonne National Laboratory. The other authors were Argonnes Abhinav Prakash as well as Pritzker School of Molecular Engineering graduate student Gregory Grant. The team used the U.S. Department of Energys Center for Nanoscale Materials user facility at Argonne National Laboratory.

Citation: Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks. Konda et al, ACS Nano, April 24, 2020. https://doi.org/10.1021/acsnano.0c03252

Funding: partly supported by the U.S. Department of Defense Vannevar Bush Fellowship

Link:
Homemade masks made of silk and cotton may boost protection - UChicago News

Nanomedicines Market will touch a new level in upcoming year with Top Key Players like Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer,…

Posted on by

Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine uses nanoscale manipulation of materials to improve medicine delivery. Thus, nanomedicine has facilitated the treatment against various diseases. Nanomedicine is in nascent stage, as several products are in the development phase. According to Nanobiotix (a nanomedicine company), in 2015, around 230 nanomedicine products were identified, which are either marked or are in the trial phase.

Get the PDF Sample Copy of this Report:

https://www.a2zmarketresearch.com/sample?reportId=20562

This report covers Nanomedicines market from the bottom line, starting from its definition. Later, it segments the market on various criteria to give a depth of understanding on the various product types and pricing structures and applications. Each and every segment is examined carefully by factoring in sales, revenue and market size in order to understand the potential of growth and scope.

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Nanomedicines market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Nanomedicines markets trajectory between forecast periods.

Some of the Top Companies Profiled in this Market includes:

Global Nanomedicines Market Segmentation:

Market Segmentation: By Product

Market Segmentation: By Nanomolecule Type

Market Segmentation: By Application

Get Special Discount Upto 30% on this Report:

https://www.a2zmarketresearch.com/discount?reportId=20562

Key questions answered in the report include:

Table of Contents

Global Nanomedicines Market Research Report

Chapter 1 Nanomedicines Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Nanomedicines Market Forecast

Buy Exclusive Research Report:

https://www.a2zmarketresearch.com/buy?reportId=20562

If you have any special requirements, please let us know and we will offer you the report as you want.

See the rest here:
Nanomedicines Market will touch a new level in upcoming year with Top Key Players like Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer,...

Nanomedicine Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 – Cole of Duty

Posted on by

A new market report by Market Research Intellect on the Nanomedicine Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Nanomedicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=201321&utm_source=COD&utm_medium=888

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Nanomedicine manufacturers/companies operating at both regional and global levels:

Sales and sales broken down by Product:

Sales and sales divided by Applications:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Nanomedicine Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=201321&utm_source=COD&utm_medium=888

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Nanomedicine. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Market Research Intellect

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=201321&utm_source=COD&utm_medium=888

Customization of the Report:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Nanomedicine market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Read more here:
Nanomedicine Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of Duty